- GVHD; Bone marrow transplant - graft-versus-host disease; Stem cell transplant - graft-versus-host disease; Allogeneic transplant - GVHD ... Elsevier; 2020:chap 28. Reddy P, Ferrara JLM. Graft-versus-host disease and graft-versus-leukemia responses. In: Hoffman R, ...
- ... National Cancer Institute (US) ; 2002-. Search term Complications, Graft-Versus-Host Disease, and Late Effects After Pediatric Hematopoietic Stem Cell ... resistant to therapy. Table 4. Staging of Acute Graft-Versus-Host Disease (GVHD) a View in own window Stage Skin ...
- ... See Table 6 and Table 7 .) Table 6. Graft-Versus-Host Disease Classification View in own window Category (Acute and ... stem cell transplant. Table 7. Clinical Features of Graft-Versus-Host Disease (GVHD) View in own window System/Organ Acute ...
- ... were only applied in the year of treatment. Graft versus host disease Graft versus host disease (GVHD) is a severe complication that is possible ... episode. No reference costs could be found for graft versus host disease. All costs associated with transplantation up to 100 ...
- ... who receive transplants have an increased risk of graft-versus-host disease. Graft-versus-host disease (GVHD) occurs when your tissue reacts to bone ...
- ... Sandimmune], tacrolimus [Astagraf, Prograf]) and methotrexate to prevent graft-versus-host disease (GVHD; a complication of hematopoietic stem-cell transplant [ ...
- ... hydroxyurea. Ruxolitinib is also used to treat acute graft versus host disease (aGVHD; a complication of hematopoietic stem-cell transplant [ ...
- Belumosudil is used to treat graft versus host disease (GVHD; a complication of hematopoietic stem-cell transplant [HSCT; a procedure that replaces diseased bone marrow with healthy bone marrow]) in ...
- Axatilimab-csfr injection is used to treat graft versus host disease (GVHD; a condition in which the immune system begins attacking newly transplanted organs, stem cells or bone marrow) in adults and some children ...
- ... modality effects (therapeutic interactions). Blood product transfusion. Chronic graft-versus-host disease. Host-related factors: Sex. Genetic predisposition. Premorbid, comorbid, ...
497 results